LANGUAGE, STIGMA, AND PEOPLE WITH OPIOID USE DISORDERS

This presentation will address stigma against opioid use disorder from the perspective of social psychology/public health, review the impacts of stigma on treatment and recovery, and discuss the importance of person first and non-stigmatizing language in clinical interactions and medical documentation. Particular emphasis will be placed on medical mistrust and the importance of building trust in the context of the criminalization of substance use. This presentation draws not only on the relevant scientific research, but also the presenter’s lived experience of addiction and recovery.

Target Audience

Physicians, Nurse Practitioners, Physician Assistants

Learning Objectives

  • Define stigma and understand its impact on people with Opioid Use Disorders.
  • Identify stigmatizing language and develop a more objective, medical vocabulary.
  • Understand the consequences of stigmatizing language in patient documentation

Additional Information

Partner: 
Warren Alpert Medical School of Brown University
State Approved: 
Connecticut
Massachusetts
Rhode Island
Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Attendance
Course opens: 
12/17/2020
Course expires: 
12/17/2022
Rating: 
0

Guest Speaker
Jon Soske, PhD
Post-Doctoral Research Associate
Lifespan Transitions Clinic
Associate Researcher, COBRE on Opioids and Overdoes
Special Projects Director, RICARES | Providence, RI

Faculty Disclosure

In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.

This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.

Faculty Disclosure/Conflict of Interest

The following speaker and planning committee members have disclosed that they have no relevant financial relationships:
Speaker: Jon Soske, PhD
Planning Committee Members: Rahul Vanjani, MD, MSc, Maria Sullivan

This presentation includes discussion of unlabeled/investigational use of a commercial product.

Disclaimer and Privacy Policy

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.

Accreditation
The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians. 

Credit Designation
Physicians: The Warren Alpert Medical School of Brown University designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. 

Rhode Island Specific: This program qualifies for 0.25 hour CME Credit in Opioid Pain Management/Chronic Pain Management, one of the required areas of section 6.0; 6.2.1 Rhode Island CME re-licensure requirements.

Other Healthcare Professionals: Participants will receive a Certificate of Attendance stating this program is designated for 0.25 hours AMA PRA Category 1 Credits™. This credit is accepted by the AAPA and AANP.

AVAILABLE CREDIT

0.25 AMA PRA Category 1 Credit™

The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

0.25 Attendance

Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.

Available Credit

  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Attendance
Please login or register to take this course.

This course is offered through The Warren Alpert Medical School of Brown University. 

To take this course you will be redirected to The Warren Alpert Medical School of Brown University's website. You must login or create an account with The Warren Alpert Medical School of Brown University in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!